Darnax Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 17-06-2024
- Paid Up Capital ₹ 2.10 M
as on 17-06-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -11.44%
(FY 2022)
- Profit 3.43%
(FY 2022)
- Ebitda 18.65%
(FY 2022)
- Net Worth 52.79%
(FY 2022)
- Total Assets 22.04%
(FY 2022)
About Darnax Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rekha Hiran, Dariyadevi Hiran, and Naresh Hiran serve as directors at the Company.
- CIN/LLPIN
U24100MH2011PTC220735
- Company No.
220735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Darnax Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Hiran  | Additional Director | 07-Feb-2023 | Current |
| Rekha Hiran | Director | 01-Mar-2018 | Current |
| Dariyadevi Hiran | Director | 09-Aug-2011 | Current |
Financial Performance of Darnax Pharma.
Darnax Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.44% decrease. The company also saw a slight improvement in profitability, with a 3.43% increase in profit. The company's net worth Soared by an impressive increase of 52.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Darnax Pharma?
In 2022, Darnax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sunflower Trading And Investment Pvt LtdActive 35 years 4 months
Dariyadevi Hiran is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Darnax Pharma?
Unlock and access historical data on people associated with Darnax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Darnax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darnax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
